| Bioactivity | KRAS inhibitor-38 (Example 18) is a KRAS inhibitor that effectively suppresses the activity of KRAS G12C, KRAS G12D, and KRAS G12V in vivo[1]. |
| CAS | 3059496-10-2 |
| Formula | C53H68ClF2N9O8S |
| Molar Mass | 1064.68 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jianguo Chen, et al. Tricyclic compounds for the treatment of cancer. Patents, WO2024208934, 2024-10-10. |
KRAS inhibitor-38
CAS: 3059496-10-2 F: C53H68ClF2N9O8S W: 1064.68
KRAS inhibitor-38 (Example 18) is a KRAS inhibitor that effectively suppresses the activity of KRAS G12C, KRAS G12D, and
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.